Clario: Christopher Fikry, CEO

Clario has named Christopher Fikry as the new CEO, replacing retiring Joe Eazor. Fikry comes to the leadership of the company from Thermo Fisher Scientific, where he served as president of the analytical services division; he also served at PPD, Novartis, and Quest Laboratories.

In its announcement, the Clario board commented, “Christopher’s long experience and commitment to supporting global biopharma and biotech companies, our key customers, in bringing new medicines to patients faster, safer and more cost effectively is right in line with Clario’s mission. He has demonstrated strong leadership to his teams and customers alike. We would also like to thank Joe for his leadership in successfully bringing together the two predecessor companies, ERT and BioClinica, to form Clario, successfully navigating the pandemic, and creating a strong team and culture in the new organization​.”